High Lipoprotein(a) Is a Predictor of Adverse Events and Heart Failure in Patients With Acute Myocardial Infarction
Background: Lipoprotein(a) (Lp(a)) is a well-established risk factor for atherosclerotic cardiovascular disease, but its prognostic role after acute myocardial infarction (AMI) remains unclear. This study investigated the association between Lp(a) and major adverse cardiovascular events (MACE), including heart failure (HF) with preserved ejection fraction (HFpEF), in patients with AMI.
Authors
- Saki Nobuta
- Yukihiro Hashimoto
- Yasuki Nakada (ORCID: https://orcid.org/0000-0003-0510-6923)
- Kenji Onoue (ORCID: https://orcid.org/0000-0003-3233-4913)
- Shungo Hikoso (ORCID: https://orcid.org/0000-0003-2284-1970)
- Tomoya Ueda (ORCID: https://orcid.org/0000-0002-0656-3336)
- Hitoshi Nakagawa (ORCID: https://orcid.org/0000-0002-1394-8509)
- Atsushi Kyodo (ORCID: https://orcid.org/0009-0000-0271-9324)
- Taku Nishida (ORCID: https://orcid.org/0000-0001-7025-0310)
- Akihiko Okamura
- Yang Wang
Institutions
- Nara Medical University (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1253/circj.cj-26-0268
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nara Medical University